Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Medtronic
McKesson
Dow
Express Scripts

Last Updated: June 29, 2022

Details for New Drug Application (NDA): 020929


✉ Email this page to a colleague

« Back to Dashboard

NDA 020929 describes PULMICORT RESPULES, which is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. Additional details are available on the PULMICORT RESPULES profile page.

The generic ingredient in PULMICORT RESPULES is budesonide. There are twenty-two drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the budesonide profile page.
Summary for 020929
Tradename:PULMICORT RESPULES
Applicant:Astrazeneca
Ingredient:budesonide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020929
Medical Subject Heading (MeSH) Categories for 020929
Suppliers and Packaging for NDA: 020929
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929 NDA AstraZeneca Pharmaceuticals LP 0186-1988 0186-1988-04 6 POUCH in 1 CARTON (0186-1988-04) > 5 AMPULE in 1 POUCH > 2 mL in 1 AMPULE
PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929 NDA AstraZeneca Pharmaceuticals LP 0186-1989 0186-1989-04 6 POUCH in 1 CARTON (0186-1989-04) > 5 AMPULE in 1 POUCH > 2 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;INHALATIONStrength0.25MG/2ML
Approval Date:Aug 8, 2000TE:ANRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;INHALATIONStrength0.5MG/2ML
Approval Date:Aug 8, 2000TE:ANRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;INHALATIONStrength1MG/2ML
Approval Date:Aug 8, 2000TE:ANRLD:Yes

Expired US Patents for NDA 020929

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929-001 Aug 8, 2000 See Plans and Pricing See Plans and Pricing
Astrazeneca PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929-003 Aug 8, 2000 See Plans and Pricing See Plans and Pricing
Astrazeneca PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929-002 Aug 8, 2000 See Plans and Pricing See Plans and Pricing
Astrazeneca PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929-001 Aug 8, 2000 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Moodys
Express Scripts
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.